ArticleBMC gastroenterology2025

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.

Jinfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.